Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CONNASDAQ:GHNYSE:HIMSNASDAQ:OPCH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCONConcentra Group Holdings Parent$21.05+0.3%$21.44$18.89▼$24.81$2.70BN/A739,262 shs95,206 shsGHGuardant Health$50.64+4.3%$44.52$20.14▼$52.92$6.27B1.382.13 million shs510,838 shsHIMSHims & Hers Health$43.52+3.7%$48.71$13.47▼$72.98$9.75B2.0933.17 million shs40.72 million shsOPCHOption Care Health$32.00+3.1%$32.06$21.39▼$35.53$5.24B0.741.93 million shs368,267 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCONConcentra Group Holdings Parent+0.94%-1.60%-0.88%-0.95%+2,094,999,900.00%GHGuardant Health-1.20%-1.52%+27.76%+4.50%+64.24%HIMSHims & Hers Health-34.72%-29.68%-23.32%+13.57%+90.02%OPCHOption Care Health-1.52%-2.42%-1.15%-11.74%+10.18%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCONConcentra Group Holdings Parent3.0694 of 5 stars3.50.02.50.02.60.01.3GHGuardant Health3.6737 of 5 stars2.53.00.04.31.52.50.6HIMSHims & Hers Health2.4383 of 5 stars2.03.00.00.01.83.31.9OPCHOption Care Health3.9788 of 5 stars2.43.00.04.23.11.71.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCONConcentra Group Holdings Parent 3.00Buy$28.5035.39% UpsideGHGuardant Health 3.00Buy$53.766.16% UpsideHIMSHims & Hers Health 2.00Hold$38.00-12.69% DownsideOPCHOption Care Health 2.88Moderate Buy$35.5010.93% UpsideCurrent Analyst Ratings BreakdownLatest CON, HIMS, OPCH, and GH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/23/2025HIMSHims & Hers HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold6/18/2025OPCHOption Care HealthJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$36.006/13/2025GHGuardant HealthMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$60.00 ➝ $65.006/11/2025HIMSHims & Hers HealthMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingEqual Weight ➝ Equal Weight$40.006/4/2025HIMSHims & Hers HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$61.00 ➝ $65.005/7/2025HIMSHims & Hers HealthDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold5/6/2025HIMSHims & Hers HealthUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMixed ➝ Mixed5/6/2025GHGuardant HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$50.00 ➝ $60.005/6/2025HIMSHims & Hers HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$35.00 ➝ $39.005/6/2025HIMSHims & Hers HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell ➝ Sell$25.00 ➝ $30.005/6/2025HIMSHims & Hers HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$61.00 ➝ $61.00(Data available from 6/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCONConcentra Group Holdings Parent$1.90B1.42$1.87 per share11.23$2.20 per share9.57GHGuardant Health$739.02M8.49N/AN/A($1.13) per share-44.81HIMSHims & Hers Health$1.78B5.46$0.24 per share182.36$2.16 per share20.15OPCHOption Care Health$5.00B1.05$1.67 per share19.17$8.25 per share3.88Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCONConcentra Group Holdings Parent$166.54M$1.3415.7116.191.968.09%29.94%6.31%7/28/2025 (Estimated)GHGuardant Health-$436.37M-$3.39N/AN/AN/A-53.82%-1,200.44%-26.77%8/6/2025 (Estimated)HIMSHims & Hers Health$126.04M$0.6963.1683.702.429.24%22.75%15.51%8/4/2025 (Estimated)OPCHOption Care Health$211.82M$1.2425.8125.401.904.12%16.90%7.00%7/30/2025 (Estimated)Latest CON, HIMS, OPCH, and GH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025CONConcentra Group Holdings Parent$0.31$0.32+$0.01$0.30$496.06 million$500.80 million5/5/2025Q1 2025HIMSHims & Hers Health$0.12$0.20+$0.08$0.20$535.21 million$586.01 million4/30/2025Q1 2025GHGuardant Health-$0.57-$0.49+$0.08-$0.77$189.91 million$203.47 million4/29/2025Q1 2025OPCHOption Care Health$0.36$0.40+$0.04$0.28$1.26 billion$1.33 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCONConcentra Group Holdings Parent$0.251.19%N/A18.66%N/AGHGuardant HealthN/AN/AN/AN/AN/AHIMSHims & Hers HealthN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/ALatest CON, HIMS, OPCH, and GH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/8/2025CONConcentra Group Holdings Parentquarterly$0.06251.2%5/20/20255/20/20255/29/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCONConcentra Group Holdings Parent5.181.101.10GHGuardant HealthN/A4.113.76HIMSHims & Hers HealthN/A1.591.32OPCHOption Care Health0.821.541.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCONConcentra Group Holdings ParentN/AGHGuardant Health92.60%HIMSHims & Hers Health63.52%OPCHOption Care Health98.05%Insider OwnershipCompanyInsider OwnershipCONConcentra Group Holdings Parent6.60%GHGuardant Health6.10%HIMSHims & Hers Health13.71%OPCHOption Care Health0.64%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCONConcentra Group Holdings Parent11,250128.17 million119.71 millionN/AGHGuardant Health2,021123.89 million116.33 millionNot OptionableHIMSHims & Hers Health1,637223.83 million184.19 millionOptionableOPCHOption Care Health8,088163.75 million162.70 millionOptionableCON, HIMS, OPCH, and GH HeadlinesRecent News About These CompaniesOption Care Health’s Q1 Earnings Call: Our Top 5 Analyst QuestionsJune 23 at 7:39 AM | finance.yahoo.comOption Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Avior Wealth Management LLCJune 22 at 4:22 AM | marketbeat.comSG Americas Securities LLC Makes New Investment in Option Care Health, Inc. (NASDAQ:OPCH)June 21 at 3:29 AM | marketbeat.comRiverbridge Partners LLC Has $50.64 Million Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)June 20, 2025 | marketbeat.comJanney Capital Management LLC Purchases New Position in Option Care Health, Inc. (NASDAQ:OPCH)June 20, 2025 | marketbeat.comOption Care Health (NASDAQ:OPCH) Earns "Market Outperform" Rating from JMP SecuritiesJune 20, 2025 | americanbankingnews.comOption Care Health, Inc. (NASDAQ:OPCH) Receives $35.50 Average Price Target from BrokeragesJune 20, 2025 | americanbankingnews.com1OPCH : Forecasting The Future: 5 Analyst Projections For Option Care HealthJune 18, 2025 | benzinga.comJMP Securities Reaffirms "Market Outperform" Rating for Option Care Health (NASDAQ:OPCH)June 18, 2025 | marketbeat.comOption Care Health, Inc. (NASDAQ:OPCH) Given Consensus Recommendation of "Moderate Buy" by BrokeragesJune 17, 2025 | marketbeat.comAssenagon Asset Management S.A. Lowers Position in Option Care Health, Inc. (NASDAQ:OPCH)June 15, 2025 | marketbeat.comFort Washington Investment Advisors Inc. OH Trims Holdings in Option Care Health, Inc. (NASDAQ:OPCH)June 13, 2025 | marketbeat.comHere’s Why Option Care Health (OPCH) Surged in Q1June 12, 2025 | msn.comGAMMA Investing LLC Acquires 110,776 Shares of Option Care Health, Inc. (NASDAQ:OPCH)June 12, 2025 | marketbeat.comHarbor Capital Advisors Inc. Reduces Position in Option Care Health, Inc. (NASDAQ:OPCH)June 11, 2025 | marketbeat.comOption Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Wedge Capital Management L L P NCJune 10, 2025 | marketbeat.com12,062 Shares in Option Care Health, Inc. (NASDAQ:OPCH) Acquired by Squarepoint Ops LLCJune 7, 2025 | marketbeat.comUnpacking Q1 Earnings: Option Care Health (NASDAQ:OPCH) In The Context Of Other Senior Health, Home Health & Hospice StocksJune 5, 2025 | msn.comTwo Sigma Investments LP Purchases 99,070 Shares of Option Care Health, Inc. (NASDAQ:OPCH)June 1, 2025 | marketbeat.com111 Capital Takes Position in Option Care Health, Inc. (NASDAQ:OPCH)May 31, 2025 | marketbeat.comJohn Hancock Small Cap Core Fund Q1 2025 CommentaryMay 30, 2025 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesNavitas Soars on NVIDIA Deal: Breaking Down Its Tech and OutlookBy Leo Miller | May 27, 2025View Navitas Soars on NVIDIA Deal: Breaking Down Its Tech and OutlookBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefensePalantir Scores First $1 Billion Contract; Is It Priced In?By Chris Markoch | May 27, 2025View Palantir Scores First $1 Billion Contract; Is It Priced In?Applied Digital: Now the High-Stakes Race to Build BeginsBy Jeffrey Neal Johnson | June 17, 2025View Applied Digital: Now the High-Stakes Race to Build BeginsArcher's Midnight Air Taxi Soars, But Stock Doesn’t BudgeBy Jeffrey Neal Johnson | June 4, 2025View Archer's Midnight Air Taxi Soars, But Stock Doesn’t BudgeCON, HIMS, OPCH, and GH Company DescriptionsConcentra Group Holdings Parent NYSE:CON$21.05 +0.07 (+0.33%) As of 12:32 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation.Guardant Health NASDAQ:GH$50.64 +2.09 (+4.30%) As of 12:31 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Hims & Hers Health NYSE:HIMS$43.52 +1.54 (+3.68%) As of 12:32 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.Option Care Health NASDAQ:OPCH$32.00 +0.95 (+3.07%) As of 12:32 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Geospace Stock Skyrockets After Major Petrobras Contract CrowdStrike Eyes Breakout as Cyber Threats Boost Demand Microsoft Stock Holds Steady as AI Drives Workforce Shift Top International ETFs With Dividends and Market-Beating Returns D-Wave Goes International With South Korea Partnership Don’t Miss These 2 Small Quantum Stocks Poised to Pop BigBear.ai Poised to Benefit as Palantir Dominates AI Defense Why Hims & Hers Stock Could Be a Multi-Bagger in the Making Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
